Can CBD Cure Anxiety Disorders?
Anxiety disorder is a mental health condition that involves a feeling of insecurity and fear. People having serious anxiety symptoms suffer from panic attacks, intense situations where they feel insecure, and fear or terror....
Read More
Seven Emerging Job Opportunities in Weed
Got a bad case of the Mondays? Maybe a career shift is in order… Here are some emerging job opportunities in weed.
Read More
5 Qualities a Dispensary Budtender Needs to Have
As world markets continue to be affected by the Coronavirus (COVID-19), corporations in all...
Read More
FEATURED NEWS
The Company reported a net loss of $22.0 million, or $0.56 per basic and diluted share, for the first quarter of 2019. In this trial, EPIDIOLEX met its primary endpoint, which was the reduction in seizure frequency compared to baseline of the Epidiolex 25 mg/kg/day dose group vs placebo (p=0.0009). The discussion about the company’s growth and global ambition to provide premium hemp-derived and CBD-based products to consumers who are looking for a different approach to health care.Cara Therapeutics Reports First Quarter 2019 Financial Results
GW Pharmaceuticals Reports Positive Phase 3 Pivotal Trial Results for EPIDIOLEX® (cannabidiol) Oral Solution in Patients with Seizures Associated With Tuberous Sclerosis Complex
Wildflower Brands Inc. Featured in Exclusive NetworkNewsWire Broadcast
LATEST STOCK NEWS
Future Farm Technologies Inc. is pleased to announce that it has completed the drying and curing phase of its crop of hemp and seeds in Maine. Company financials and corporate update will be filed after market on November 28, 2019. Auxly closed a $123.0 million investment and R&D partnership with Imperial Brands.Future Farm Prepares Maine-Grown Hemp Biomass and Seeds for Processing and Market
WeedMD to Host Third Quarter 2019 Earnings Conference Call on November 29 at 10 a.m. Eastern Time
Auxly Reports Q3 2019 Financial Results
GET LISTED
